Skip to content

The analgesic effect of acupuncture combined with ultrasound-guided RISS block on patients undergoing thoracoscopic radical resection of lung cancer and its impact on early postoperative rehabilitation: A three-arm randomized controlled clinical trial

The analgesic effect of acupuncture combined with ultrasound-guided RISS block on patients undergoing thoracoscopic radical resection of lung cancer and its impact on early postoperative rehabilitation: A three-arm randomized controlled clinical trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124285
Enrollment
Unknown
Registered
2026-05-09
Start date
2026-05-11
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Group A (Experimental Group):True acupuncture + bilateral RISS block + postoperative PCIA
Group B (Placebo group):Sham acupuncture + bilateral RISS block + postoperative PCIA
Group C (Positive Control Group ):No acupuncture +bilateral RISS block + postoperative PCIA

Sponsors

Foshan Nanhai District People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–75 years, no gender limitation; 2. Pathologically confirmed non-small cell lung cancer, planned to undergo elective unilateral thoracoscopic radical lung cancer surgery; 3. American Society of Anesthesiologists (ASA) classification I–III; 4. Preoperative resting VAS score <3 points; 5. Conscious, able to communicate well with researchers, and cooperate to complete study assessments; 6. Voluntarily participating in this study and signing a written informed consent form;

Exclusion criteria

Exclusion criteria: 1. Severe combined heart, lung, liver, or kidney dysfunction (e.g., NYHA Class IV heart failure, respiratory failure requiring long-term oxygen therapy); 2. Contraindications to acupuncture (e.g., coagulation disorders: INR >1.5 or platelets <80×10^9/L; skin infection or damage at the puncture site; history of fainting during needle insertion); 3. Known allergy to ropivacaine, sufentanil, or other drugs related to this study; 4. History of chest surgery within 3 months prior to surgery; 5. Long-term use of analgesics before surgery or a history of chronic pain; 6. Presence of cognitive impairment or history of mental illness making assessment cooperation impossible; 7. Pregnant or breastfeeding women; 8. Currently participating in other clinical trials that may interfere with the results of this study; 9. Other conditions deemed by the investigator to be unsuitable for participation in this study;

Design outcomes

Primary

MeasureTime frame
VAS scores at rest and during activity at 2, 6, 12, and 48 hours after surgery;

Secondary

MeasureTime frame
The number of effective PCIA compressions during 0-24 hours and 24-48 hours after surgery;Proportion of patients requiring rescue analgesia and total dose of rescue medication (converted to sufentanil-equivalent dose);VAS score at rest at 24 hours after surgery;Early postoperative rehabilitation indicators included first ambulation time (hours), first exhaust time (hours), chest drainage tube indwelling time (days), postoperative hospital stay (days);

Countries

China

Contacts

Public ContactLi Qijin

Foshan Nanhai District People’s Hospital

214111799@qq.com+86 757 6682 0890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026